Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline for lymphangioleiomyomatosis
RBR-6g8yz9Phase 3Completed
- Sponsor
- Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
- Start
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of doxycycline in lymphangioleiomyomatosis (LAM), sponsored by Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo. Started Jan 2011; status: completed.
02
Drugs
doxycycline
03
Conditions
lymphangioleiomyomatosis (LAM)
Beyond the preview
Go deeper on RBR-6g8yz9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6g8yz9.